What is the current Price Target for the Kezar Life Sciences Inc stock?

The average Kezar Life Sciences Inc target price is $12.50. This is 201.21% higher than the current stock price. The highest price target is 333.73%, the lowest is 68.67%. 2 Analysts have issued a price target Kezar Life Sciences Inc 2026 .

How high will the Kezar Life Sciences Inc stock rise?

No reliable answer can be given as to how high the Kezar Life Sciences Inc stock will rise. The performance of stocks, including the Kezar Life Sciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kezar Life Sciences Inc stock today?

The performance of Kezar Life Sciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kezar Life Sciences Inc stock fall?

The decline in Kezar Life Sciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kezar Life Sciences Inc Forecast, price target & analysts

$4.15

0.24%

Nasdaq, Apr 21, 10:00 pm CET

ISIN

US49372L1008

Symbol

KZR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Kezar Life Sciences Inc Target price 2025 - Analyst rating & recommendation

Kezar Life Sciences Inc Classifications & Recommendation:

Buy

60%

Hold

40%

Kezar Life Sciences Inc Price Target

Target Price	$12.50
Price	$4.15
Potential	201.21% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Kezar Life Sciences Inc 2026 . The average Kezar Life Sciences Inc target price is $12.50. This is 201.21% register free of charge higher than the current stock price. The highest price target is $18.00 333.73% register free of charge , the lowest is $7.00 68.67% register free of charge .
	A rating was issued by 5 analysts: 3 Analysts recommend Kezar Life Sciences Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kezar Life Sciences Inc stock has an average upside potential 2026 of 201.21% register free of charge . Most analysts recommend the Kezar Life Sciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-11.49	-9.10
	18.16%	20.80%
P/E		negative

2 Analysts have issued a Kezar Life Sciences Inc forecast for earnings per share. The average Kezar Life Sciences Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-11.49	18.16%
2025	$-9.10 20.80% Unlock
2026	$-7.04 22.64% Unlock
2027	$-7.80 10.80% Unlock
2028	$-8.35 7.05% Unlock
2029	$-9.30 11.38% Unlock

Current	-0.36	40.98%
2025	-0.46 27.78% Unlock
2026	-0.59 28.26% Unlock
2027	-0.53 10.17% Unlock
2028	-0.50 5.66% Unlock
2029	-0.45 10.00% Unlock

Kezar Life Sciences Inc...

Current Kezar Life Sciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wells Fargo	Locked ➜ Locked	Locked	Dec 19 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 02 2024
Wells Fargo	Locked ➜ Locked	Locked	Nov 14 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 18 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 14 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 02 2024

Analyst Rating	Date
Locked Wells Fargo: Locked ➜ Locked	Dec 19 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 02 2024
Locked Wells Fargo: Locked ➜ Locked	Nov 14 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 18 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 14 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 02 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 59.18%

Infineon 54.07%

Amazon.com 51.90%

Meta Platforms (Facebook) 49.74%

Snowflake 47.61%

Walt Disney 47.00%

Alibaba Group Holding Ltd 46.73%

NIO ADR 46.33%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now